(S)-Pomalidomide

• UNSPSC Description:

  (S)-Pomalidomide ((S)-CC-4047) is an angiogenesis-inhibiting drug with growth-inhibitory activity against B-cell tumors. (S)-Pomalidomide can induce complete tumor regression in BurKitt lymphoma cells. (S)-Pomalidomide serves as an immunomodulator with potential applications in inhibiting hematological malignancies[1].

• Target Antigen:

  Endogenous Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/s-pomalidomide.html

• Smiles:

  O=C1N([C@@H](CC2)C(NC2=O)=O)C(C3=C1C=CC=C3N)=O

• Molecular Weight:

  273.24

• References & Citations:

  [1]Modeling and simulation to probe the pharmacokinetic disposition of pomalidomide R- and S-enantiomers

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  202271-89-4